291 related articles for article (PubMed ID: 31018246)
1. Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders.
Posset R; Gropman AL; Nagamani SCS; Burrage LC; Bedoyan JK; Wong D; Berry GT; Baumgartner MR; Yudkoff M; Zielonka M; Hoffmann GF; Burgard P; Schulze A; McCandless SE; Garcia-Cazorla A; Seminara J; Garbade SF; Kölker S;
Ann Neurol; 2019 Jul; 86(1):116-128. PubMed ID: 31018246
[TBL] [Abstract][Full Text] [Related]
2. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision.
Häberle J; Burlina A; Chakrapani A; Dixon M; Karall D; Lindner M; Mandel H; Martinelli D; Pintos-Morell G; Santer R; Skouma A; Servais A; Tal G; Rubio V; Huemer M; Dionisi-Vici C
J Inherit Metab Dis; 2019 Nov; 42(6):1192-1230. PubMed ID: 30982989
[TBL] [Abstract][Full Text] [Related]
3. Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders.
Posset R; Garcia-Cazorla A; Valayannopoulos V; Teles EL; Dionisi-Vici C; Brassier A; Burlina AB; Burgard P; Cortès-Saladelafont E; Dobbelaere D; Couce ML; Sykut-Cegielska J; Häberle J; Lund AM; Chakrapani A; Schiff M; Walter JH; Zeman J; Vara R; Kölker S;
J Inherit Metab Dis; 2016 Sep; 39(5):661-672. PubMed ID: 27106216
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychological attributes of urea cycle disorders: A systematic review of the literature.
Waisbren SE; Stefanatos AK; Kok TMY; Ozturk-Hismi B
J Inherit Metab Dis; 2019 Nov; 42(6):1176-1191. PubMed ID: 31268178
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ.
Ah Mew N; Krivitzky L; McCarter R; Batshaw M; Tuchman M;
J Pediatr; 2013 Feb; 162(2):324-9.e1. PubMed ID: 22901741
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders.
Rüegger CM; Lindner M; Ballhausen D; Baumgartner MR; Beblo S; Das A; Gautschi M; Glahn EM; Grünert SC; Hennermann J; Hochuli M; Huemer M; Karall D; Kölker S; Lachmann RH; Lotz-Havla A; Möslinger D; Nuoffer JM; Plecko B; Rutsch F; Santer R; Spiekerkoetter U; Staufner C; Stricker T; Wijburg FA; Williams M; Burgard P; Häberle J
J Inherit Metab Dis; 2014 Jan; 37(1):21-30. PubMed ID: 23780642
[TBL] [Abstract][Full Text] [Related]
7. Improving long term outcomes in urea cycle disorders-report from the Urea Cycle Disorders Consortium.
Waisbren SE; Gropman AL; ; Batshaw ML
J Inherit Metab Dis; 2016 Jul; 39(4):573-84. PubMed ID: 27215558
[TBL] [Abstract][Full Text] [Related]
8. Chronic liver involvement in urea cycle disorders.
Ranucci G; Rigoldi M; Cotugno G; Bernabei SM; Liguori A; Gasperini S; Goffredo BM; Martinelli D; Monti L; Francalanci P; Candusso M; Parini R; Dionisi-Vici C
J Inherit Metab Dis; 2019 Nov; 42(6):1118-1127. PubMed ID: 31260111
[TBL] [Abstract][Full Text] [Related]
9. Neonatal factors related to survival and intellectual and developmental outcome of patients with early-onset urea cycle disorders.
Pontoizeau C; Roda C; Arnoux JB; Vignolo-Diard P; Brassier A; Habarou F; Barbier V; Grisel C; Abi-Warde MT; Boddaert N; Kuster A; Servais A; Kaminska A; Hennequin C; Dupic L; Lesage F; Touati G; Valayannopoulos V; Chadefaux-Vekemans B; Oualha M; Eisermann M; Ottolenghi C; de Lonlay P
Mol Genet Metab; 2020 Jun; 130(2):110-117. PubMed ID: 32273051
[TBL] [Abstract][Full Text] [Related]
10. Ammonia control in children ages 2 months through 5 years with urea cycle disorders: comparison of sodium phenylbutyrate and glycerol phenylbutyrate.
Smith W; Diaz GA; Lichter-Konecki U; Berry SA; Harding CO; McCandless SE; LeMons C; Mauney J; Dickinson K; Coakley DF; Moors T; Mokhtarani M; Scharschmidt BF; Lee B
J Pediatr; 2013 Jun; 162(6):1228-34, 1234.e1. PubMed ID: 23324524
[TBL] [Abstract][Full Text] [Related]
11. Self-reported treatment-associated symptoms among patients with urea cycle disorders participating in glycerol phenylbutyrate clinical trials.
Nagamani SC; Diaz GA; Rhead W; Berry SA; Le Mons C; Lichter-Konecki U; Bartley J; Feigenbaum A; Schulze A; Longo N; Berquist W; Gallagher R; Bartholomew D; Harding CO; Korson MS; McCandless SE; Smith W; Vockley J; Kronn D; Zori R; Cederbaum S; Merritt JL; Wong D; Coakley DF; Scharschmidt BF; Dickinson K; Marino M; Lee BH; Mokhtarani M
Mol Genet Metab; 2015; 116(1-2):29-34. PubMed ID: 26296711
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of phenylbutyrate metabolites by UPLC-MS/MS demonstrates inverse correlation of phenylacetate:phenylacetylglutamine ratio with plasma glutamine levels.
Jiang Y; Almannai M; Sutton VR; Sun Q; Elsea SH
Mol Genet Metab; 2017 Nov; 122(3):39-45. PubMed ID: 28888854
[TBL] [Abstract][Full Text] [Related]
13. Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate.
Diaz GA; Krivitzky LS; Mokhtarani M; Rhead W; Bartley J; Feigenbaum A; Longo N; Berquist W; Berry SA; Gallagher R; Lichter-Konecki U; Bartholomew D; Harding CO; Cederbaum S; McCandless SE; Smith W; Vockley G; Bart SA; Korson MS; Kronn D; Zori R; Merritt JL; C S Nagamani S; Mauney J; Lemons C; Dickinson K; Moors TL; Coakley DF; Scharschmidt BF; Lee B
Hepatology; 2013 Jun; 57(6):2171-9. PubMed ID: 22961727
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
[TBL] [Abstract][Full Text] [Related]
15. Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.
Kido J; Matsumoto S; Mitsubuchi H; Endo F; Nakamura K
Metab Brain Dis; 2018 Oct; 33(5):1517-1523. PubMed ID: 29948653
[TBL] [Abstract][Full Text] [Related]
16. Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan.
Kido J; Matsumoto S; Häberle J; Inomata Y; Kasahara M; Sakamoto S; Horikawa R; Tanemura A; Okajima H; Suzuki T; Nakamura K
J Inherit Metab Dis; 2021 Nov; 44(6):1311-1322. PubMed ID: 34232532
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan.
Kido J; Matsumoto S; Häberle J; Nakajima Y; Wada Y; Mochizuki N; Murayama K; Lee T; Mochizuki H; Watanabe Y; Horikawa R; Kasahara M; Nakamura K
J Inherit Metab Dis; 2021 Jul; 44(4):826-837. PubMed ID: 33840128
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2months to 2years.
Berry SA; Longo N; Diaz GA; McCandless SE; Smith WE; Harding CO; Zori R; Ficicioglu C; Lichter-Konecki U; Robinson B; Vockley J
Mol Genet Metab; 2017 Nov; 122(3):46-53. PubMed ID: 28916119
[TBL] [Abstract][Full Text] [Related]
19. Newborn screening for proximal urea cycle disorders: Current evidence supporting recommendations for newborn screening.
Merritt JL; Brody LL; Pino G; Rinaldo P
Mol Genet Metab; 2018 Jun; 124(2):109-113. PubMed ID: 29703588
[TBL] [Abstract][Full Text] [Related]
20. Physical, cognitive, and social status of patients with urea cycle disorders in Japan.
Kido J; Matsumoto S; Ito T; Hirose S; Fukui K; Kojima-Ishii K; Mushimoto Y; Yoshida S; Ishige M; Sakai N; Nakamura K
Mol Genet Metab Rep; 2021 Jun; 27():100724. PubMed ID: 33614409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
